TOFAJAK
Brand Name: TOFAJAK
Composition: Tofacitinib Tablets 5 mg
Quantity: 60 Tablets
Manufacturer: Cipla
Product Description
Medical Info
TOFAJAK, containing 5 mg of Tofacitinib, is a potent JAK inhibitor prescribed for adults with moderate to severe rheumatoid arthritis or active psoriatic arthritis, primarily when standard therapies are ineffective. By selectively blocking the Janus kinase enzymes, Tofajak interrupts critical intracellular signaling pathways involved in chronic inflammation. This action effectively reduces pain, swelling, and stiffness, helps prevent progressive joint damage, and improves physical function in patients. Due to its immunomodulatory effects, Tofajak requires close medical supervision and is indicated only as a prescription medication to manage serious autoimmune conditions. Full safety profiles must be reviewed.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
